OncoAlert and ecancer ASCO roundup - Day 1

Incidence and trends of HPV-related cancers in the United States

Long term outcome of enfortumab vedotin + pembrolizumab in first line locally advanced or metastatic urothelial carcinoma

European Cancer Organisation: Time To Act

OncoAlert and ecancer weekly roundup for April 19 - 25, 2021

PC14586: The first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma

Assessing comprehensive score for financial toxicity (COST) among radiation oncology patients in India

Highlights from AORTIC Cancer Genomics Conference 2021

The Conquering Cancer Campaign

Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)

Managing the treatment of NSCLC patients during the COVID-19 pandemic (DE)